Catalyst Pharmaceuticals Inc. (CPRX)
NASDAQ · Healthcare
Catalyst Pharmaceuticals Inc. Gross Profit 2012–2025
Catalyst Pharmaceuticals Inc. annual/quarterly gross profit history and growth rate from 2019 to 2026. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- Catalyst Pharmaceuticals Inc. gross profit for the quarter ending March 31, 2026 was 134.9 M, a 9.23% increase year-over-year.
- Catalyst Pharmaceuticals Inc. gross profit for the twelve months ending March 31, 2026 was 510.1 M, a 30.39% increase year-over-year.
- Catalyst Pharmaceuticals Inc. annual gross profit for 2025 was 501.7 M, a 18.64% increase from 2024.
- Catalyst Pharmaceuticals Inc. annual gross profit for 2024 was 422.9 M, a 22.14% increase from 2023.
- Catalyst Pharmaceuticals Inc. annual gross profit for 2023 was 346.2 M, a 92.56% increase from 2022.
- Catalyst Pharmaceuticals Inc. annual gross profit for 2022 was 179.8 M.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Catalyst Pharmaceuticals Inc. Gross Profit — FAQ
Catalyst Pharmaceuticals Inc. (CPRX) gross profit over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
What is Catalyst Pharmaceuticals Inc.'s gross profit?
Catalyst Pharmaceuticals Inc. (CPRX) reported gross profit of $502M for fiscal 2025.
Where can I see CPRX's gross profit history?
The chart and table above show Catalyst Pharmaceuticals Inc.'s gross profit by year and by quarter, including the growth rate.